Updates are available Correction dated 2021-02-03
Click to view Correction: https://doi.org/10.1038/s41586-020-03177-5
-
Authors
Minikel, Eric Vallabh
Karczewski, Konrad J. http://orcid.org/0000-0003-2878-4671
Martin, Hilary C.
Cummings, Beryl B.
Whiffin, Nicola
Rhodes, Daniel
Alföldi, Jessica http://orcid.org/0000-0001-9713-6200
Trembath, Richard C.
van Heel, David A. http://orcid.org/0000-0002-0637-2265
Daly, Mark J. http://orcid.org/0000-0002-0949-8752
,
Alföldi, Jessica
Armean, Irina M.
Banks, Eric
Bergelson, Louis
Cibulskis, Kristian
Collins, Ryan L.
Connolly, Kristen M.
Covarrubias, Miguel
Cummings, Beryl B.
Daly, Mark J.
Donnelly, Stacey
Farjoun, Yossi
Ferriera, Steven
Francioli, Laurent
Gabriel, Stacey
Gauthier, Laura D.
Gentry, Jeff
Gupta, Namrata
Jeandet, Thibault
Kaplan, Diane
Karczewski, Konrad J.
Laricchia, Kristen M.
Llanwarne, Christopher
Minikel, Eric V.
Munshi, Ruchi
Neale, Benjamin M.
Novod, Sam
O’Donnell-Luria, Anne H.
Petrillo, Nikelle
Poterba, Timothy
Roazen, David
Ruano-Rubio, Valentin
Saltzman, Andrea
Samocha, Kaitlin E.
Schleicher, Molly
Seed, Cotton
Solomonson, Matthew
Soto, Jose
Tiao, Grace
Tibbetts, Kathleen
Tolonen, Charlotte
Vittal, Christopher
Wade, Gordon
Wang, Arcturus
Wang, Qingbo
Ware, James S.
Watts, Nicholas A.
Weisburd, Ben
Whiffin, Nicola
,
Aguilar Salinas, Carlos A.
Ahmad, Tariq
Albert, Christine M.
Ardissino, Diego
Atzmon, Gil
Barnard, John
Beaugerie, Laurent
Benjamin, Emelia J.
Boehnke, Michael
Bonnycastle, Lori L.
Bottinger, Erwin P.
Bowden, Donald W.
Bown, Matthew J.
Chambers, John C.
Chan, Juliana C.
Chasman, Daniel
Cho, Judy
Chung, Mina K.
Cohen, Bruce
Correa, Adolfo
Dabelea, Dana
Daly, Mark J.
Darbar, Dawood
Duggirala, Ravindranath
Dupuis, Josée
Ellinor, Patrick T.
Elosua, Roberto
Erdmann, Jeanette
Esko, Tõnu
Färkkilä, Martti
Florez, Jose
Franke, Andre
Getz, Gad
Glaser, Benjamin
Glatt, Stephen J.
Goldstein, David
Gonzalez, Clicerio
Groop, Leif
Haiman, Christopher
Hanis, Craig
Harms, Matthew
Hiltunen, Mikko
Holi, Matti M.
Hultman, Christina M.
Kallela, Mikko
Kaprio, Jaakko
Kathiresan, Sekar
Kim, Bong-Jo
Kim, Young Jin
Kirov, George
Kooner, Jaspal
Koskinen, Seppo
Krumholz, Harlan M.
Kugathasan, Subra
Kwak, Soo Heon
Laakso, Markku
Lehtimäki, Terho
Loos, Ruth J. F.
Lubitz, Steven A.
Ma, Ronald C. W.
MacArthur, Daniel G.
Marrugat, Jaume
Mattila, Kari M.
McCarroll, Steven
McCarthy, Mark I.
McGovern, Dermot
McPherson, Ruth
Meigs, James B.
Melander, Olle
Metspalu, Andres
Neale, Benjamin M.
Nilsson, Peter M.
O’Donovan, Michael C.
Ongur, Dost
Orozco, Lorena
Owen, Michael J.
Palmer, Colin N. A.
Palotie, Aarno
Park, Kyong Soo
Pato, Carlos
Pulver, Ann E.
Rahman, Nazneen
Remes, Anne M.
Rioux, John D.
Ripatti, Samuli
Roden, Dan M.
Saleheen, Danish
Salomaa, Veikko
Samani, Nilesh J.
Scharf, Jeremiah
Schunkert, Heribert
Shoemaker, Moore B.
Sklar, Pamela
Soininen, Hilkka
Sokol, Harry
Spector, Tim
Sullivan, Patrick F.
Suvisaari, Jaana
Tai, E. Shyong
Teo, Yik Ying
Tiinamaija, Tuomi
Tsuang, Ming
Dan Turner, Teresa
Tusie-Luna, Teresa
Vartiainen, Erkki
Vawter, Marquis P.
Ware, James. S.
Watkins, Hugh
Weersma, Rinse K.
Wessman, Maija
Wilson, James G.
Xavier, Ramnik J.
Schreiber, Stuart L.
MacArthur, Daniel G. http://orcid.org/0000-0002-5771-2290
- License Information
-
More Information
Article History
Received: 25 January 2019
Accepted: 10 February 2020
First Online: 27 May 2020
Change Date: 3 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-020-03177-5
Competing interests
: E.V.M. has received research support in the form of charitable contributions from Charles River Laboratories and Ionis Pharmaceuticals, and has consulted for Deerfield Management. K.J.K. is a shareholder of Personalis. H.C.M., B.B.C., M.W., D.R. and J.A. have no competing interests to declare. R.C.T. serves on the Scientific Advisory Board of Ipsen Ltd and has current funding from the Wellcome Trust and the National Institute for Health Research UK. D.A.v.H. is a shareholder of Nexpep Pty Ltd; has current or recent research funding from Wellcome Trust, Medical Research Council UK, National Institute for Health Research UK, Alnylam Pharmaceuticals; and serves on the Population & Systems Medicine Board of the Medical Research Council UK. MJD is a founder of Maze Therapeutics. S.L.S. serves on the Board of Directors of the Genomics Institute of the Novartis Research Foundation (‘GNF’); is a shareholder and serves on the Board of Directors of Jnana Therapeutics; is a shareholder of Forma Therapeutics; is a shareholder and advises Decibel Therapeutics and Eikonizo Therapeutics; serves on the Scientific Advisory Boards of Eisai Co., Ltd., Ono Pharma Foundation, Exo Therapeutics, and F-Prime Capital Partners; and is a Novartis Faculty Scholar. D.G.M. is a founder with equity in Goldfinch Bio, and has received research support from AbbVie, Astellas, Biogen, BioMarin, Eisai, Merck, Pfizer, and Sanofi-Genzyme.
